chr9-126690862-G-A
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM2PM5PP3_StrongPP5
The NM_001174147.2(LMX1B):c.353G>A(p.Cys118Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C118F) has been classified as Pathogenic.
Frequency
Consequence
NM_001174147.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LMX1B | NM_001174147.2 | c.353G>A | p.Cys118Tyr | missense_variant | 3/8 | ENST00000373474.9 | NP_001167618.1 | |
LMX1B | NM_001174146.2 | c.353G>A | p.Cys118Tyr | missense_variant | 3/8 | NP_001167617.1 | ||
LMX1B | NM_002316.4 | c.353G>A | p.Cys118Tyr | missense_variant | 3/8 | NP_002307.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LMX1B | ENST00000373474.9 | c.353G>A | p.Cys118Tyr | missense_variant | 3/8 | 1 | NM_001174147.2 | ENSP00000362573.3 | ||
LMX1B | ENST00000355497.10 | c.353G>A | p.Cys118Tyr | missense_variant | 3/8 | 1 | ENSP00000347684.5 | |||
LMX1B | ENST00000526117.6 | c.353G>A | p.Cys118Tyr | missense_variant | 3/8 | 1 | ENSP00000436930.1 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Nail-patella syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Molecular Diagnostics Laboratory, M Health Fairview: University of Minnesota | Nov 18, 2020 | - - |
Nail-patella syndrome;C0403548:Nail-patella-like renal disease Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 25, 2024 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 25, 2023 | This sequence change replaces cysteine, which is neutral and slightly polar, with tyrosine, which is neutral and polar, at codon 118 of the LMX1B protein (p.Cys118Tyr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with nail-patella syndrome (PMID: 10571942). This variant is also known as C95Y. ClinVar contains an entry for this variant (Variation ID: 995576). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt LMX1B protein function with a positive predictive value of 80%. This variant disrupts the p.Cys118 amino acid residue in LMX1B. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9618165). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at